Katarzyna Kania

1.0k total citations · 1 hit paper
35 papers, 844 citations indexed

About

Katarzyna Kania is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katarzyna Kania has authored 35 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katarzyna Kania's work include Drug Transport and Resistance Mechanisms (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Katarzyna Kania is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Katarzyna Kania collaborates with scholars based in Poland, United Kingdom and United States. Katarzyna Kania's co-authors include W. C. Wagner, Wojciech M. Ciszewski, Stephen B. Hladky, Margery A. Barrand, Łukasz Pułaski, Marzena Szwed, Aneta Koceva‐Chyła, Zofia Jóźwiak, Z. Jóźwiak and Janusz Skierski and has published in prestigious journals such as Nature, Scientific Reports and Brain Research.

In The Last Decade

Katarzyna Kania

33 papers receiving 839 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comprehensive spatio-cellular map of the human hypothalamus

2025 29 citations Katarzyna Kania et al. profile →

Peers

Countries citing papers authored by Katarzyna Kania

Since Specialization

Citations

This map shows the geographic impact of Katarzyna Kania's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Kania with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Kania more than expected).

Fields of papers citing papers by Katarzyna Kania

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Kania. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Kania. The network helps show where Katarzyna Kania may publish in the future.

Co-authorship network of co-authors of Katarzyna Kania

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Kania. A scholar is included among the top collaborators of Katarzyna Kania based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Kania. Katarzyna Kania is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Miłosz Wilczyński, Jacek R. Wilczyński, Katarzyna Kania, (unknown), Andrzej Malinowski, Ewelina Perdas, (unknown), Edyta Paradowska	2
2	Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer 2024 ·Scientific Reports ·Edyta Paradowska, (unknown), Katarzyna Kania, (unknown), Miłosz Wilczyński, Andrzej Malinowski, (unknown), (unknown), Jacek R. Wilczyński	0
3	New SDS-Based Polyelectrolyte Multicore Nanocarriers for Paclitaxel Delivery—Synthesis, Characterization, and Activity against Breast Cancer Cells 2023 ·Cells ·Marzena Szwed, Sylwia Michlewska, Katarzyna Kania, (unknown), Agnieszka Marczak, Krzysztof Szczepanowicz	2
4	The Toll-like Receptor 4 Polymorphism Asp299Gly Is Associated with an Increased Risk of Ovarian Cancer 2022 ·Cells ·Katarzyna Kania, (unknown), Jacek R. Wilczyński, Miłosz Wilczyński, (unknown), Andrzej Malinowski, Edyta Paradowska	10
5	RT-qPCR-based tests for SARS-CoV-2 detection in pooled saliva samples for massive population screening to monitor epidemics 2022 ·Scientific Reports ·Michał Różański, Aurelia Walczak‐Drzewiecka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maciej Borowiec, Katarzyna Kania, Edyta Paradowska, Jakub Pawełczyk, Jarosław Dziadek, Jarosław Dastych	6
6	Interaction of Adenosine, Modified Using Carborane Clusters, with Ovarian Cancer Cells: A New Anticancer Approach against Chemoresistance 2021 ·Cancers ·Katarzyna Bednarska, (unknown), Katarzyna Kania, Marzena Szwed, (unknown), Bohumı́r Grüner, Zbigniew J. Leśnikowski	15
7	Lactate Suppresses Retroviral Transduction in Cervical Epithelial Cells through DNA-PKcs Modulation 2021 ·International Journal of Molecular Sciences ·W. C. Wagner, Katarzyna Sobierajska, Katarzyna Kania, Edyta Paradowska, Wojciech M. Ciszewski	8
8	CdSe/ZnS Core-Shell-Type Quantum Dot Nanoparticles Disrupt the Cellular Homeostasis in Cellular Blood–Brain Barrier Models 2021 ·International Journal of Molecular Sciences ·Katarzyna Kania, W. C. Wagner, Łukasz Pułaski	15
9	Nitroxide Radical-Containing Redox Nanoparticles Protect Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine Toxicity 2020 ·Oxidative Medicine and Cellular Longevity ·(unknown), Łukasz Pułaski, Katarzyna Kania, Ireneusz Stefaniuk, (unknown), (unknown), Grzegorz Bartosz, Izabela Sadowska‐Bartosz	16
10	Stimulation of lactate receptor (HCAR1) affects cellular DNA repair capacity 2017 ·DNA repair ·W. C. Wagner, Katarzyna Kania, Wojciech M. Ciszewski	39
11	L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation 2015 ·Cell Communication and Signaling ·W. C. Wagner, Wojciech M. Ciszewski, Katarzyna Kania	151
12	Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells 2015 ·Leukemia Research ·Marzena Szwed, Katarzyna Kania, Zofia Jóźwiak	6
13	Doxorubicin–transferrin conjugate triggers pro-oxidative disorders in solid tumor cells 2015 ·Toxicology in Vitro ·Marzena Szwed, (unknown), Katarzyna Kania, Aneta Koceva‐Chyła, Agnieszka Marczak	18
14	Changes in the activity of antioxidant barrier after treatment of K562 and CCRF-CEM cell lines with doxorubicin–transferrin conjugate 2014 ·Biochimie ·Marzena Szwed, Katarzyna Kania, Zofia Jóźwiak	7
15	Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin 2014 ·Cellular Oncology ·Marzena Szwed, Katarzyna Kania, Zofia Jóźwiak	15
16	Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin–transferrin conjugate in human leukemia cell lines 2014 ·Leukemia & lymphoma ·Marzena Szwed, Katarzyna Kania, Zofia Jóźwiak	7
17	P‐glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia–reoxygenation 2009 ·Journal of Neurochemistry ·(unknown), Katarzyna Kania, Stephen B. Hladky, Margery A. Barrand	32
18	Activation of β‐catenin signalling by GSK‐3 inhibition increases p‐glycoprotein expression in brain endothelial cells 2008 ·Journal of Neurochemistry ·(unknown), Katarzyna Kania, (unknown), Sangeeta Chawla, Jaswinder K. Sethi, Łukasz Pułaski, Ignacio A. Romero, P. O. Couraud, Babette B. Weksler, Stephen B. Hladky, Margery A. Barrand	140
19	Involvement of reactive oxygen species in aclarubicin-induced death of human trisomic and diabetic fibroblasts 2007 ·Toxicology in Vitro ·Katarzyna Kania, (unknown), Zofia Jóźwiak	8
20	Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activation 2005 ·APOPTOSIS ·Aneta Koceva‐Chyła, (unknown), Janusz Skierski, Katarzyna Kania, Z. Jóźwiak	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact